Related references
Note: Only part of the references are listed.The acetate recovery factor to correct tracer-derived dietary fat oxidation in humans
Audrey Bergouignan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system
Silke Meiners et al.
HYPERTENSION (2008)
Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase/Hsp22
Nadia Hedhli et al.
CARDIOVASCULAR RESEARCH (2008)
Sex-specific regulation of gene expression in the aging monkey aorta
Hongyu Qiu et al.
PHYSIOLOGICAL GENOMICS (2007)
Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations
Saul R. Powell et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy
Christophe Depre et al.
CIRCULATION (2006)
Endoplasmic reticulum stress signaling in disease
Stefan J. Marciniak et al.
PHYSIOLOGICAL REVIEWS (2006)
Absence of NF-κB subunit p50 improves heart failure after myocardial infarction
Stefan Frantz et al.
FASEB JOURNAL (2006)
The ubiquitin-proteasome system in cardiac physiology and pathology
Saul R. Powell
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload
H Matsusaka et al.
HYPERTENSION (2006)
Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate
AF Kisselev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Protein turnover in cardiac cell growth and survival
N Hedhli et al.
CARDIOVASCULAR RESEARCH (2005)
Endoplasmic reticulum stress: cell life and death decisions
CY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-α
M Eto et al.
CIRCULATION (2005)
Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue
L Chen et al.
CANCER RESEARCH (2005)
H11 has dose-dependent and dual hypertrophic and proapoptotic functions in cardiac myocytes
M Hase et al.
BIOCHEMICAL JOURNAL (2005)
Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity
K van Leyen et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway
V Stangl et al.
FASEB JOURNAL (2004)
Program of cell survival underlying human and experimental hibernating myocardium
C Depre et al.
CIRCULATION RESEARCH (2004)
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload
JR McMullen et al.
CIRCULATION (2004)
The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling
JS Janicki et al.
HEART FAILURE REVIEWS (2004)
Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome
S Meiners et al.
HYPERTENSION (2004)
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
AH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Rapamycin attenuates load-induced cardiac hypertrophy in mice
T Shioi et al.
CIRCULATION (2003)
Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury
J Pye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
H11 kinase is a novel mediator of myocardial hypertrophy in vivo
C Depre et al.
CIRCULATION RESEARCH (2002)
Molecular and cellular mechanisms of myocardial remodeling
M Maytin et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2002)
A proteasome inhibitor confers cardioprotection
H Lüss et al.
CARDIOVASCULAR RESEARCH (2002)
Involvement of nuclear factor-κB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy
S Hirotani et al.
CIRCULATION (2002)
Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress
G Esposito et al.
CIRCULATION (2002)
Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic β-subunits
BM Kessler et al.
CHEMISTRY & BIOLOGY (2001)
Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes
NH Purcell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
A Ducharme et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target
FG Spinale et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
